Nov [NOV] vs Baker Hughes Company [BKR] Detailed Stock Comparison
Nov
NYSE
Loading...
Baker Hughes Company
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Nov wins in 6 metrics, Baker Hughes Company wins in 14 metrics, with 0 ties. Baker Hughes Company appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Nov | Baker Hughes Company | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.02 | 14.22 | Nov |
| Price-to-Book Ratio | 0.70 | 2.42 | Nov |
| Debt-to-Equity Ratio | 36.15 | 33.77 | Baker Hughes Company |
| PEG Ratio | 7.78 | 16.93 | Nov |
| EV/EBITDA | 4.94 | 9.84 | Nov |
| Profit Margin (TTM) | 5.36% | 11.04% | Baker Hughes Company |
| Operating Margin (TTM) | 6.54% | 12.84% | Baker Hughes Company |
| EBITDA Margin (TTM) | 6.54% | 12.84% | Baker Hughes Company |
| Return on Equity | 7.38% | 18.36% | Baker Hughes Company |
| Return on Assets (TTM) | 4.45% | 5.85% | Baker Hughes Company |
| Free Cash Flow (TTM) | $953.00M | $2.05B | Baker Hughes Company |
| Dividend Yield | 1.52% | 2.41% | Baker Hughes Company |
| 1-Year Return | -35.10% | 21.74% | Baker Hughes Company |
| Price-to-Sales Ratio (TTM) | 0.51 | 1.55 | Nov |
| Enterprise Value | $5.85B | $46.01B | Baker Hughes Company |
| EV/Revenue Ratio | 0.67 | 1.67 | Nov |
| Gross Profit Margin (TTM) | 20.38% | 23.37% | Baker Hughes Company |
| Revenue per Share (TTM) | $23 | $28 | Baker Hughes Company |
| Earnings per Share (Diluted) | $1.21 | $3.06 | Baker Hughes Company |
| Beta (Stock Volatility) | 1.28 | 0.89 | Baker Hughes Company |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Nov vs Baker Hughes Company Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Nov | -3.58% | -13.17% | -6.11% | 2.10% | -15.12% | -17.48% |
| Baker Hughes Company | -3.42% | -5.52% | 12.46% | 20.23% | -8.21% | 4.69% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Nov | -35.10% | -29.84% | 1.17% | -69.47% | -67.69% | -52.80% |
| Baker Hughes Company | 21.74% | 80.84% | 162.58% | -21.91% | 4.27% | -24.17% |
Performance & Financial Health Analysis: Nov vs Baker Hughes Company
| Metric | NOV | BKR |
|---|---|---|
| Market Information | ||
| Market Cap | $4.50B | $42.90B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 5,074,810 | 11,124,730 |
| 90 Day Avg. Volume | 4,584,703 | 8,799,640 |
| Last Close | $12.13 | $43.51 |
| 52 Week Range | $10.84 - $20.77 | $32.25 - $49.40 |
| % from 52W High | -41.60% | -11.92% |
| All-Time High | $86.55 (Sep 01, 2014) | $100.29 (Oct 15, 2007) |
| % from All-Time High | -85.98% | -56.62% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | -0.03% |
| Quarterly Earnings Growth | -0.52% | 0.21% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.11% |
| Operating Margin (TTM) | 0.07% | 0.13% |
| Return on Equity (TTM) | 0.07% | 0.18% |
| Debt to Equity (MRQ) | 36.15 | 33.77 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $17.45 | $17.96 |
| Cash per Share (MRQ) | $2.91 | $3.13 |
| Operating Cash Flow (TTM) | $1.28B | $3.42B |
| Levered Free Cash Flow (TTM) | $821.75M | $1.10B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.52% | 2.41% |
| Last 12-Month Dividend | $0.21 | $1.11 |
Valuation & Enterprise Metrics Analysis: Nov vs Baker Hughes Company
| Metric | NOV | BKR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.02 | 14.22 |
| Forward P/E | 7.78 | 16.93 |
| PEG Ratio | 7.78 | 16.93 |
| Price to Sales (TTM) | 0.51 | 1.55 |
| Price to Book (MRQ) | 0.70 | 2.42 |
| Market Capitalization | ||
| Market Capitalization | $4.50B | $42.90B |
| Enterprise Value | $5.85B | $46.01B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.67 | 1.67 |
| Enterprise to EBITDA | 4.94 | 9.84 |
| Risk & Other Metrics | ||
| Beta | 1.28 | 0.89 |
| Book Value per Share (MRQ) | $17.45 | $17.96 |
Financial Statements Comparison: Nov vs Baker Hughes Company
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NOV | BKR |
|---|---|---|
| Revenue/Sales | $2.10B | $6.43B |
| Cost of Goods Sold | $1.66B | $4.95B |
| Gross Profit | $447.00M | $1.48B |
| Research & Development | N/A | $146.00M |
| Operating Income (EBIT) | $152.00M | $752.00M |
| EBITDA | $232.00M | $897.00M |
| Pre-Tax Income | $121.00M | $561.00M |
| Income Tax | $47.00M | $152.00M |
| Net Income (Profit) | $74.00M | $409.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NOV | BKR |
|---|---|---|
| Cash & Equivalents | $1.16B | $3.28B |
| Total Current Assets | $5.78B | $16.84B |
| Total Current Liabilities | $2.18B | $12.59B |
| Long-Term Debt | $2.23B | $5.97B |
| Total Shareholders Equity | $6.49B | $17.21B |
| Retained Earnings | $-583.00M | $-5.44B |
| Property, Plant & Equipment | $2.49B | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NOV | BKR |
|---|---|---|
| Operating Cash Flow | $280.00M | $569.00M |
| Capital Expenditures | $-84.00M | N/A |
| Free Cash Flow | $51.00M | $409.00M |
| Debt Repayment | $-4.00M | N/A |
| Common Stock Repurchase | $-81.00M | $-188.00M |
Short Interest & Institutional Ownership Analysis
| Metric | NOV | BKR |
|---|---|---|
| Shares Short | 29.95M | 25.59M |
| Short Ratio | 6.57 | 3.46 |
| Short % of Float | 0.17% | 0.03% |
| Average Daily Volume (10 Day) | 5,074,810 | 11,124,730 |
| Average Daily Volume (90 Day) | 4,584,703 | 8,799,640 |
| Shares Outstanding | 381.55M | 989.53M |
| Float Shares | 368.04M | 983.59M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 1.07% | 1.01% |
Dividend Analysis & Yield Comparison: Nov vs Baker Hughes Company
| Metric | NOV | BKR |
|---|---|---|
| Last 12-Month Dividend | $0.21 | $1.11 |
| Last 12-Month Dividend Yield | 1.52% | 2.41% |
| 3-Year Avg Annual Dividend | $0.21 | $0.89 |
| 3-Year Avg Dividend Yield | 0.35% | 0.60% |
| 3-Year Total Dividends | $0.63 | $2.68 |
| Ex-Dividend Date | Mar 14, 2025 | Aug 05, 2025 |